Evidence map›Paper›PMID 31527660›Full record

ArticleScientific reports2019

Kazuki Takada, Gouji Toyokawa, Yasuto Yoneshima, Kentaro Tanaka, Isamu Okamoto, Mototsugu Shimokawa, Sho Wakasu, Akira Haro, Atsushi Osoegawa, Tetsuzo Tagawa and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05260606 (Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer), which is not on this map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05260606 unknown statusnot on this mapstarted 2022, after this paper: background citation

Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer: Prospective Observational Study

Typeobservational_patient_registrySponsorSamsung Medical CenterRan2022 to 2025Enrolled100ConditionsCarcinoma, Non-Small-Cell Lung, Immune Checkpoint InhibitorsArmsF-18 FDG PET/CT
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Comparison of pre-treatmentEuropean radiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. The utility ofCancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  7. Article
  8. The role of baselineTherapeutic advances in medical oncology · 2024
    Review
  9. Review
  10. Patlak-Ki derived from ultra-high sensitivity dynamic total body [European journal of nuclear medicine and molecular imaging · 2023
    Article
  11. Article
  12. Review
  13. Molecular imaging to support cancer immunotherapy.Journal for immunotherapy of cancer · 2022
    Review
  14. Prospective assessment usingScientific reports · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Metabolic parameters on baselineFrontiers in medicine · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kazuki TakadaDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. k_takada@surg2.med.kyushu-u.ac.jp.ORCID http://orcid.org/0000-0001-6377-9291
Gouji ToyokawaDepartment of Thoracic Surgery, National Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 810-8563, Japan.
Yasuto YoneshimaResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Kentaro TanakaResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Isamu OkamotoResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Mototsugu ShimokawaClinical Research Institute, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan.
Sho WakasuDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Akira HaroDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Atsushi OsoegawaDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Tetsuzo TagawaDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Yoshinao OdaDepartment of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Yoichi NakanishiResearch Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Masaki MoriDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Kyushu University · JPNational Kyushu Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To examine the association between

Indexed as

AdultAgedAged, 80 and overBiomarkers, PharmacologicalCarcinoma, Non-Small-Cell LungFemaleFluorodeoxyglucose F18HumansImmunotherapyLung NeoplasmsLymphatic MetastasisLymph NodesMaleMiddle AgedNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyBiomarkers, PharmacologicalFluorodeoxyglucose F18PDCD1 protein, humanProgrammed Cell Death 1 ReceptorRadiopharmaceuticals

Identifiers

PMID31527660
PMCPMC6746703
OpenAlexW2974313870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.